Biotechnology Assets S.A. (BST) — Financial Flexibility Index
Biotechnology Assets S.A. (BST) has a Financial Flexibility Index of 0.09x as of June 2025. Free cash flow of €660.12K (operating CF €658.13K minus capex €1.99K) represents 0% of total liabilities (€7.01 Million). Check total reinvestment intensity of Biotechnology Assets S.A. to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Biotechnology Assets S.A. Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Biotechnology Assets S.A. across 11 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Biotechnology Assets S.A..
Annual Financial Flexibility Index for Biotechnology Assets S.A. (2014–2024)
Year-by-year free cash flow to debt coverage for Biotechnology Assets S.A.. Explore Biotechnology Assets S.A. debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.08x | €646.88K | €-73.85K | €8.17 Million | ▲ +113.4% |
| 2023 | 0.04x | €373.71K | €47.74K | €10.08 Million | ▼ -99.7% |
| 2022 | 14.37x | €209.79 Million | €-1.73 Million | €14.60 Million | ▲ +26655.3% |
| 2021 | -0.05x | €-840.64K | €-1.50 Million | €15.54 Million | ▼ -109.6% |
| 2020 | 0.56x | €9.19 Million | €8.79 Million | €16.37 Million | ▲ +722.1% |
| 2019 | -0.09x | €-7.68 Million | €-15.16 Million | €85.11 Million | ▼ -186.2% |
| 2018 | -0.03x | €-1.83 Million | €-13.02 Million | €58.04 Million | ▼ -116.9% |
| 2017 | 0.19x | €1.78 Million | €213.49K | €9.56 Million | ▼ -75.1% |
| 2016 | 0.75x | €5.98 Million | €2.71 Million | €8.02 Million | ▲ +340.0% |
| 2015 | 0.17x | €1.23 Million | €158.16K | €7.23 Million | ▲ +251.6% |
| 2014 | 0.05x | €338.07K | €-303.79K | €7.01 Million | — |